Erratum to: Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
Authors:
Open Access
- 26 May 2017
- journal article
- correction
- Published by Springer Nature in Advances in Therapy
- Vol. 34 (7) , 1773-1774